Data through FY2026 Q3 (Jun 30, 2026)
Granules Pharmaceuticals Inc.
Company profile for Granules Pharmaceuticals Inc. covers 98 filings across the reporting window. FY2026 certified median offer: $83,928.
- FY2026 certified median
- $83,928
- Total filings
- 98
- FY2026 25th–75th percentile
- $60,580–$104,166
- Top job title
- Pharmaceutical Manufacturing Quality Control Analyst
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 7 | $121,000 | $76,500 | $121,000 |
| FY2025 | 49 | $75,000 | $62,639 | $110,636 |
| FY2026 (Q1–Q3) | 42 | $83,928 | $60,580 | $104,166 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Pharmaceutical Manufacturing Quality Control Analyst12 filings
- Biochemist8 filings
- Biochemist I4 filings
- Compliance Officer3 filings
- Pharmaceutical Manufacturing QC Analyst3 filings
- Process Engineer3 filings
- Scientist II3 filings
- Associate Chemist (Stability Data Analyst)2 filings
- Associate Director2 filings
- Associate Director, Demand Planning2 filings